BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26872)

  • 1. Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications.
    Baylin SB; Weisburger WR; Eggleston JC; Mendelsohn G; Beaven MA; Abeloff MD; Ettinger DS
    N Engl J Med; 1978 Jul; 299(3):105-10. PubMed ID: 26872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of L-dopa decarboxylase and diamine oxidase (histaminase) in human lung cancers and decarboxylase as a marker for small (oat) cell cancer in cell culture.
    Baylin SB; Abeloff MD; Goodwin G; Carney DN; Gazdar AF
    Cancer Res; 1980 Jun; 40(6):1990-4. PubMed ID: 6245807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated histaminase (diamine oxidase) activity in small-cell carcinoma of the lung.
    Baylin SB; Abeloff MD; Wieman KC; Tomford JW; Ettinger DS
    N Engl J Med; 1975 Dec; 293(25):1286-90. PubMed ID: 171575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine-related biochemistry in the spectrum of human lung cancers.
    Baylin SB; Jackson RD; Goodwin G; Gazdar AF
    Exp Lung Res; 1982 Nov; 3(3-4):209-23. PubMed ID: 6132808
    [No Abstract]   [Full Text] [Related]  

  • 5. Endocrine-related biochemistry in the spectrum of human lung carcinoma.
    Berger CL; Goodwin G; Mendelsohn G; Eggleston JC; Abeloff MD; Aisner S; Baylin SB
    J Clin Endocrinol Metab; 1981 Aug; 53(2):422-9. PubMed ID: 6114110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
    Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
    Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dibutyryl cyclic adenosine 3':5'-monophosphate on the growth of cultured human small-cell lung carcinoma and the specific cellular activity of L-dopa decarboxylase.
    Francis J; Thompson R; Bernal SD; Luk GD; Baylin SB
    Cancer Res; 1983 Feb; 43(2):639-45. PubMed ID: 6293702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic and biological significance of cellular heterogeneity in medullary thyroid carcinoma: a study of calcitonin, L-dopa decarboxylase, and histaminase.
    Lippman SM; Mendelsohn G; Trump DL; Wells SA; Baylin SB
    J Clin Endocrinol Metab; 1982 Feb; 54(2):233-40. PubMed ID: 6798062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of histaminase and L-DOPA decarboxylase activity in the transition from C-cell hyperplasia to familial medullary thyroid carcinoma.
    Baylin SB; Mendelsohn G; Weisburger WR; Gann DS; Eggleston JC
    Cancer; 1979 Oct; 44(4):1315-21. PubMed ID: 115572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.
    Gazdar AF; Carney DN; Nau MM; Minna JD
    Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA methylation patterns of the calcitonin gene in human lung cancers and lymphomas.
    Baylin SB; Höppener JW; de Bustros A; Steenbergh PH; Lips CJ; Nelkin BD
    Cancer Res; 1986 Jun; 46(6):2917-22. PubMed ID: 3009002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma.
    Matsuki Y; Tanimoto A; Hamada T; Sasaguri Y
    Mod Pathol; 2003 Jan; 16(1):72-8. PubMed ID: 12527716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of creatine kinase and its BB isoenzyme in lung cancer specimens and cultures.
    Gazdar AF; Zweig MH; Carney DN; Van Steirteghen AC; Baylin SB; Minna JD
    Cancer Res; 1981 Jul; 41(7):2773-7. PubMed ID: 6265067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. A light microscopic and immunohistochemical study.
    Mendelsohn G; Eggleston JC; Weisburger WR; Gann DS; Baylin SB
    Am J Pathol; 1978 Jul; 92(1):35-52. PubMed ID: 99045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and identification of small cell lung cancer cell lines having classic and variant features.
    Carney DN; Gazdar AF; Bepler G; Guccion JG; Marangos PJ; Moody TW; Zweig MH; Minna JD
    Cancer Res; 1985 Jun; 45(6):2913-23. PubMed ID: 2985257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histaminase activity: a biochemical marker for medullary carcinoma of the thyroid.
    Baylin SB; Beaven MA; Buja LM; Keiser HR
    Am J Med; 1972 Dec; 53(6):723-33. PubMed ID: 4628882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
    Gilbert JA; Frederick LM; Ames MM
    Clin Cancer Res; 2000 Nov; 6(11):4365-72. PubMed ID: 11106255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the biology of small cell lung cancer.
    Carney DN
    Eur J Respir Dis Suppl; 1987; 149():5-9. PubMed ID: 3034648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.